10986057

Source:http://linkedlifedata.com/resource/pubmed/id/10986057

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007097, umls-concept:C0008838, umls-concept:C0042066, umls-concept:C0045093, umls-concept:C0086409, umls-concept:C0144576, umls-concept:C0205179, umls-concept:C0205390, umls-concept:C0227598, umls-concept:C0278627, umls-concept:C1257890, umls-concept:C2603343
pubmed:issue	18
pubmed:dateCreated	2000-10-6
pubmed:abstractText	To determine the maximum-tolerated dose and the antitumor activity of a combination of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma (TCC) of the urothelium.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0732-183X
pubmed:author	pubmed-author:AlbanellJJ, pubmed-author:BanúsJ MJM, pubmed-author:BaselgaJJ, pubmed-author:BastúsRR, pubmed-author:Batiste-AlentornEE, pubmed-author:BellmuntJJ, pubmed-author:CarlesJJ, pubmed-author:ClimentM AMA, pubmed-author:Cortés-FunesHH, pubmed-author:Diaz-RubioEE, pubmed-author:FongLL, pubmed-author:GallardoEE, pubmed-author:González-LarribaJ LJL, pubmed-author:GuillemVV, pubmed-author:López-BreaMM, pubmed-author:NoguéMM, pubmed-author:Paz-AresLL, pubmed-author:SáenzAA, pubmed-author:de la CruzJ JJJ
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3247-55
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10986057-Adult, pubmed-meshheading:10986057-Aged, pubmed-meshheading:10986057-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10986057-Carcinoma, Transitional Cell, pubmed-meshheading:10986057-Cisplatin, pubmed-meshheading:10986057-Deoxycytidine, pubmed-meshheading:10986057-Dose Fractionation, pubmed-meshheading:10986057-Humans, pubmed-meshheading:10986057-Male, pubmed-meshheading:10986057-Middle Aged, pubmed-meshheading:10986057-Paclitaxel, pubmed-meshheading:10986057-Survival Analysis, pubmed-meshheading:10986057-Urologic Neoplasms
pubmed:year	2000
pubmed:articleTitle	Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.
pubmed:affiliation	Hospital General Universitari Vall d'Hebron, Bacelona, Spain. bellmunt@hg.vhebron.ed
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Clinical Trial, Phase I